Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the …

Mahner, S, W Meier, Du Bois, C Brown, D Lorusso, A Ferrero, J Cretin, and . 2011. “Carboplatin and Pegylated Liposomal Doxorubicin versus Carboplatin and Paclitaxel in Very Platinum-Sensitive Ovarian Cancer Patients: Results from a Subset Analysis of The …”. Journal of Clinical Oncology 29 (15_suppl) 5059.
Last updated on 08/05/2026